In summary, this study demonstrated that serum miR-25 might play an important role in a clinical setting for cancer early diagnosis and prognosis prediction, especially for lung cancer in an Asian population; while tissue miR-92a may be a suitable biomarker for cancer detection, and this family might function through targeting RGS3. This evidence concerns the gene RGS3 and lung carcinoma.